title: Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
abstract: The aim of this retrospective study is to investigate the frequency and severity of ovarian hyperstimulation syndrome and the pregnancy rate in a patient collective at risk who received bromocriptine treatment.
authors.affiliation: IVF Centers Prof. Zech, Salzburg, Austria.
authors.forename: Dietmar
authors.initials: D
authors.lastname: Spitzer
authors.forename: Johannes
authors.initials: J
authors.lastname: Wogatzky
authors.forename: Maximilian
authors.initials: M
authors.lastname: Murtinger
authors.forename: Mathias H
authors.initials: MH
authors.lastname: Zech
authors.forename: Robert
authors.initials: R
authors.lastname: Haidbauer
authors.forename: Nicolas H
authors.initials: NH
authors.lastname: Zech
mesh_terms: D000328:Adult; D001317:Austria; D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D010062:Ovulation Induction / Q000009:adverse effects*; D011247:Pregnancy; D018873:Pregnancy Rate; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D018491:Dopamine Agonists; D001971:Bromocriptine